A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan Compared to Placebo for the Treatment of Postoperative Pain

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan compared to Placebo for the Treatment of Postoperative Pain

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients Age ≥18 planning to undergo total knee arthroplasty

• ASA classes I - III

Locations
United States
California
Keck School of Medicine of USC
RECRUITING
Los Angeles
Contact Information
Primary
Pui Yan, MS
puiyan@med.usc.edu
323-442-6984
Time Frame
Start Date: 2022-09-15
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 160
Treatments
Experimental: Dextromethorphan
Placebo_comparator: Placebo
Related Therapeutic Areas
Acute Pain
Sponsors
Leads: Nathanael Heckmann

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)

A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)

Who is this study for: Patients with combined postcapillary and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
Enrollment Status: Recruiting
Publish Date: January 28, 2025
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 2

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Enrollment Status: Recruiting
Publish Date: January 13, 2025
Intervention Type: Drug
Study Phase: Phase 3

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Enrollment Status: Recruiting
Publish Date: February 17, 2025
Intervention Type: Drug
Study Phase: Phase 3